10 Results for "

GAL-9

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "GAL-9" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-P70535
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: GALectin-9; GAL-9; Ecalectin; Tumor Antigen HOM-HD-21; LGALS9
Species:  
Source:  
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P72637
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: GALectin-9; LGALs9; GAL-9
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-155175
CAS No.: 1113126-49-0
Purity:  98.93%
Target:  

Tim3 IFNAR

Research Areas:  

Cancer

TIM-3-IN-2 is a TIM-3 inhibitor. TIM-3-IN-2 blocks the interactions of TIM-3 with PtdSer, CEACAM1 and Gal-9, and inhibits the immunosuppressive function of TIM-3. TIM-3-IN-2 restores IFNγ release from peripheral blood mononuclear cells. TIM-3-IN-2 inhibits the proliferation of acute myeloid leukemia cells. TIM-3-IN-2 can be used for the research of acute myeloid leukemia .
loading...
    loading...
Cat. No.: HY-P991396

Target:  

Tim3

Research Areas:  

Cancer

LY-3321367 is a humanized IgG1 monoclonal antibody targeting TIM-3. LY-3321367 partially blocks the formation of the TIM-3/GAL-9 complex, completely blocks the binding of TIM-3 to phosphatidylserine, but does not block the formation of the TIM-3/CEACAM-1 complex. LY-3321367 is applicable to research related to various solid tumors, such as small cell lung cancer .
loading...
    loading...
Cat. No.: HY-P991198

Target:  

Tim3

Research Areas:  

Cancer

M6903 is a humanized monoclonal IgG2 antibody targeting T cell immunoglobulin and mucin domain-3 (TIM-3) (KD for human TIM-3 is 2.3 nM). M6903 binds to TIM-3, blocking the binding of TIM-3 to phosphatidylserine (PtdSer), carcinoembryonic antigen cell adhesion-related molecule 1 (CEACAM1), and galectin 9 (Gal-9), thus relieving TIM-3-mediated T cell inhibition and exerting the activities of activating antigen-specific T cells and enhancing anti-tumor immunity. M6903 is promising for research of cancers .
loading...
    loading...
Cat. No.: HY-P70696
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: GALectin-9; GAL-9; Ecalectin; Tumor antigen HOM-HD-21; LGALS9; GAL-9delta5
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P705214
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: GALectin-9; GAL-9; Ecalectin; Tumor Antigen HOM-HD-21; LGALS9
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P992454

Target:  

Tim3

Research Areas:  

Cancer

S095018 (Sym023) is a human IgG2-type inhibitor targeting T cell immunoglobulin and TIM-3. S095018 competitively blocks the binding of multiple ligands such as Gal-9 and phosphatidylserine to TIM-3. S095018 stimulates the anti-tumor activity of T cells, dendritic cells and macrophages, and exhibits good safety both as a monotherapy and in combination with the anti-PD-1 antibody Sym021. S095018 also induces an increase in the density of CD8 + T cells in the tumor microenvironment, and upregulates gene signatures associated with IFN-γ signaling, antigen presentation and T cell activation. S095018 can be used for the research of advanced/metastatic recurrent biliary tract cancer .
loading...
    loading...
Cat. No.: HY-RS16866
Research Areas:  

Others

Lgals9 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Lgals9 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P700082AF
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: G-CSF; CSF-3; MGI-1G; Pluripoietin; Molgramostin; Sargramostim
Species:  
Source:  
loading...
    loading...